Monday, February 10, 2020

Study shows how extracellular vesicles help melanoma cells to spread

A new study from Finland sheds fresh light on how melanoma cells interact with other cells via extracellular vesicles they secrete. The researchers found that extracellular vesicles secreted by melanoma cells use the so-called hedgehog signaling pathway to intensify the malignant properties of the cells they are targeting. The discovery can help in the development of better treatment and diagnostics for melanoma. Published in Cellular and Molecular Life Sciences, the study was carried out in collaboration between researchers from the University of Eastern Finland and the University of Helsinki.

Many of the mechanisms regulating the function of our body have remained unchanged throughout evolution. This means that the same genes regulate the development and function of all multicellular animals. One example of such gene survival is the so-called hedgehog signaling pathway. The gene family associated with this signaling pathway gets its unique name from a mutation it caused in fruit fly larvae, making them look spiky, just like a hedgehog. The most common of the three hedgehog genes found in mammals, the Sonic hedgehog gene, was aptly named after the famous video game character. In mammals, members of the hedgehog gene family are essential regulators of fetal development, but they are also associated with stem cell division in later stages of development and even in adults. Recent studies suggest that their expression is also associated with many different types of cancer, including skin cancers. Melanoma is the most severe form of skin cancer, and it is becoming more and more common.


Extracellular vesicles carry signals between cells - and they can also carry packaged drugs

Traditionally, signaling in the body is thought to take place via freely circulating signals, such growth factors and hormones. According to a more recent view, however, it is believed that some signals are packaged for transportation to protect them against breakage and to ensure their delivery to the correct address. Extracellular vesicles are small, bubble-like packages made of cell membrane, serving as natural carriers of signals in the body. They regulate the function of the body already during the fetal stage, via breast milk and also later in life as our tissue regenerates. Cancer cells, too, use extracellular vesicles to deliver signals and to modify their environment, making it favorable to growth. Extracellular vesicles can also be used as diverse carriers of drugs to combat diseases and to repair tissue damage - and this is why they are being studied so actively at the moment.


In the newly published study, the researchers discovered a new link between extracellular vesicles and hedgehog molecules. They found that vesicles secreted by melanoma cells intensify the malignant properties of the cells they are targeting, such as division and spreading, via the hedgehog signaling pathway. The researchers used cultured human melanoma cells and normal skin cells, confirming their findings from the cell culture by analyzing tissue samples from patients with melanoma.

It is quite a coincidence that these signal-carrying vesicles originate from cells that are also known as hedgehog cells due to their microscopically small, spike-like protrusions. These protrusions, however, don't have anything to do with fruit fly larvae; instead, they are typically found in cells that are active in producing hyaluronan, the most common sugar molecule in the extracellular matrix. Hyaluronan also plays a key role in vesicle mediated signaling, as hyaluronan found on the surface of vesicles protruding from the cell surface facilitates their binding to the target cell."  Docent Kirsi Rilla, University of Eastern Finland

The hedgehog signaling pathway holds great promise as a target for drug therapy in melanoma and other cancers. The regulation mechanism now discovered by the researchers can be made use of in the development of better diagnostics and drug therapy for patients with melanoma.

Docent Rilla's research group has been studying the biology of extracellular vesicles since 2013.


This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     
https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
 

Labels: , , , , , , , , ,

Saturday, September 14, 2019

Nano-sized cells of body may help in fighting cancer

The nano-sized cells that transfer genetic material to other cells in our body may turn into mini treatment to kill cancer cells, suggests a study.

What we've done is improve a therapeutic approach to delivering enzyme-producing genes that can convert certain drugs into toxic agents and target tumors, said the lead author of the study.


These drugs, or pro-drugs, start out as inactive compounds. But once they metabolise in the body, they're immediately activated and can get to work in fighting everything from cancer to headache. Aspirin is an example of pro-drug.


In this case, researchers used extracellular vesicles, or EVs, to deliver the enzyme-producing genes that could activate a prodrug combination therapy of ganciclovir and CB1954 in breast cancer cells.
Mini circle DNA and regular plasmid-- 2 different gene vectors that act as additional delivery mechanisms for DNA--were loaded into the vesicles to see which was better at helping transport treatment. This is known as a gene-directed enzyme, pro-drug therapy.


They found that the mini circle DNA was 14 times more effective at delivery and even more successful at killing the cancerous tumour.


Interestingly, the plasmid delivery method didn't show any tumour cell killing, the Dr. said. Yet the mini circle DNA therapy killed more than half of the breast cancer cells in the mice.


According to the researcher, this new approach could effectively become a better cancer treatment option than chemotherapy down the road.


Conventional chemotherapy isn't able to differentiate between tumours and normal tissue, so it attacks it all, he said. This non-specificity can cause severe side effects and insufficient drug concentration in tumours.


With EVs, treatment can be targeted and because of their compatibility with the human body, this type of delivery could minimise the risk of unwanted immune responses that can come with other gene therapies.


If EVs prove to be effective in humans, it would be an ideal platform for gene delivery and it could be used in humans sooner than we expect, the researcher said.


this is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   
https://gscrochetdesigns.blogspot.com. one can see my crochet creations 
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
   

Labels: , , , , , , , , ,